DiaMedica Therapeutics Inc. (DMAC) Profit Margin
DiaMedica Therapeutics Inc. (DMAC) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2018-12-31 | -1146.80% |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | N/A |
| 2023-12-31 | N/A |
| 2024-12-31 | N/A |
| 2025-12-31 | N/A |
How DMAC compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| DYAI | Dyadic International Inc. | -238.31% |
| NKTR | Nektar Therapeutics | -297.07% |
| GOSS | Gossamer Bio Inc. | -351.49% |
| KURA | Kura Oncology Inc. | -412.95% |
| VSTM | Verastem Inc. | -677.59% |
These are five companies in the same sector as DMAC with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get DiaMedica Therapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("DMAC", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | DMAC | $6.67 | +0.23% | 0.00M |
| 3 | ||||
| 4 | ||||
| 5 |